NOBEL / "prizes to those who, during the preceding year,
NOBEL / "prizes to those who, during the preceding year,
shall have conferred the greatest benefit to mankind."
Nobelprize.org
Alfred Nobel's Will
On November 27, 1895, Alfred Nobel signed his third and last will at the Swedish-Norwegian Club in Paris. When it was opened and read after his death, the will caused a lot of controversy both in Sweden and internationally, as Nobel had left much of his wealth for the establishment of a prize. His family opposed the establishment of the Nobel Prize, and the prize awarders he named refused to do what he had requested in his will. It was five years before the first Nobel Prize could be awarded in 1901.
The Establishment of the Nobel Prize
In this excerpt of the will, Alfred Nobel dictates that his entire remaining estate should be used to endow "prizes to those who, during the preceding year, shall have conferred the greatest benefit to mankind."
"The whole of my remaining realizable estate shall be dealt with in the following way: the capital, invested in safe securities by my executors, shall constitute a fund, the interest on which shall be annually distributed in the form of prizes to those who, during the preceding year, shall have conferred the greatest benefit to mankind. The said interest shall be divided into five equal parts, which shall be apportioned as follows: one part to the person who shall have made the most important discovery or invention within the field of physics; one part to the person who shall have made the most important chemical discovery or improvement; one part to the person who shall have made the most important discovery within the domain of physiology or medicine; one part to the person who shall have produced in the field of literature the most outstanding work in an ideal direction; and one part to the person who shall have done the most or the best work for fraternity between nations, for the abolition or reduction of standing armies and for the holding and promotion of peace congresses. The prizes for physics and chemistry shall be awarded by the Swedish Academy of Sciences; that for physiology or medical works by the Karolinska Institute in Stockholm; that for literature by the Academy in Stockholm, and that for champions of peace by a committee of five persons to be elected by the Norwegian Storting. It is my express wish that in awarding the prizes no consideration be given to the nationality of the candidates, but that the most worthy shall receive the prize, whether he be Scandinavian or not. "
17 Interesting Facts About Nobel Prize
Will copy:
2
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...
Continue Reading
Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...
Continue Reading
Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...
Continue Reading
ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...
Continue Reading
Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...
Continue Reading
Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....
Continue Reading
Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...
Continue Reading
Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...
Continue Reading
Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....
Continue Reading
A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...
Continue Reading
Top 5 Most Recently Viewed Articles
Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...
Continue Reading
Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...
Continue Reading
Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...
Continue Reading
Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...
Continue Reading
Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...
Continue Reading